characterized by chronic progressive weakness whose affected members harbor a novel Ca v 1.1 R1242G mutation affecting the third arginine in S4 of domain IV. Whole-cell patch clamp recordings of the R1242G mutant showed a strong hyperpolarized shift of steady-state inactivation in GLT mouse myotube expression system. The facilitated inactivation resulting in the reduction of channel availability may account for the chronic progressive weakness of the patients. In addition, we found an outward gating pore current through the mutant voltage sensor of R1242G which might induce a reduction in the amplitude and duration of the action potential and cause the failure of muscle fiber excitability. HHMI Janelia Farm, Ashburn, VA, USA. Blocking voltage-dependent Ca V 1/Ca V 2 channels is a prevailing or potential therapy for myriad diseases ranging from hypertension to Parkinson's disease, but a major limitation is lack of selective small-molecule inhibitors for distinct Ca V 1/Ca V 2 channels. Here, we report a general bio-inspired approach towards developing novel Ca V 1/Ca V 2 channel blockers (CCBs). We discovered that different proteins (Ca V b, 14-3-3, camodulin, and calmodulin-dependent protein kinase II) that bind to spatially distinct regions of pore-forming a 1 -subunit intracellular loops can be converted into CCBs, with tuneable selectivity and potency, simply by their anchoring to the plasma membrane. The principle is extendable to small molecules-engineering FKBP into specific sites within Ca V 1.2 a 1C intracellular loops permitted heterodimerizationinitiated channel inhibition with rapamycin (Fig) . The results reveal a universal method for developing novel genetically-encoded and small-molecule CCBs. -free calmodulin (apoCaM), where subsequent Ca 2þ binding to this 'resident' calmodulin (CaM) inactivates channels (Nature463:968). Channels lacking preassociated apoCaM fail to undergo CDI. Canonical L-type channels bind apoCaM so avidly that nearly all channels are 'charged' with apoCaM. However, natural variants feature potentially lower apoCaM affinity, so fluctuations in ambient apoCaM may tune overall CDI. Here, we demonstrate that channel preassociation with apoCaM does more than simply enable CDI, and strikingly enhances open probability (P O ). For example, in single-channel Ba 2þ currents (to avoid CDI), taken from a variant with low apoCaM affinity, openings are sparse under baseline apoCaM (a, left), but prolific upon apoCaM overexpression (a, right). Corresponding P O -V relations confirm this effect of apoCaM (b). Importantly, the baseline P O of differing channel variants increases with channel/apoCaM affinity via a Langmuir function (c). Thus, P O variability reflects differences in apoCaM preassociation, not contrasts in channel composition per se. These results suggest that ambient apoCaM levels can tune both CDI and P O of channels. Voltage-gated ion channels exhibit complex forms of gating, which can be targeted in pharmacological therapies for disease. Here, we report that the prooxidant, tert-butyl dihydroquinone (BHQ), modulates Cav2.1 Ca 2þ channels in ways that oppose defects in channel gating and synaptic transmission resulting from a familial hemiplegic migraine mutation (S218L). BHQ inhibits voltage-dependent activation and unmasks slow deactivation that is enhanced by Ca 2þ and more prevalent in S218L mutant than in wild-type channels. These actions of BHQ help reverse the gain-of-function and reduced Ca 2þ -dependent facilitation of Cav2.1 channels with the S218L mutation. Transgenic expression of the mutant channels at the Drosophila neuromuscular junction causes abnormally elevated evoked postsynaptic potentials and impaired synaptic plasticity, which are largely restored to the wild-type phenotypes by BHQ. Our results reveal a new mechanism by which Cav2.1 gating modifiers can correct defects associated with disease-causing mutations in Cav2.1.
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Competition between Calcium Sensors on the Voltage-Gated Calcium Channel Cav1.2 Felix Findeisen, Daniel L. Minor, Jr. UCSF, San Francisco, CA, USA. Voltage-gated calcium channel (CaV) activity is regulated by calcium sensors including calmodulin (CaM) and calcium-binding protein 1 (CaBP1). CaBP1 inhibits CaM-mediated calcium-dependent inactivation (CDI). We investigated the origins of functionally important differences between CaM and CaBP1 by creating a number of CaM/CaBP1 chimeras which suggest that both calcium sensors use their C-lobes for high affinity binding to the pore-forming CaV alpha-subunit, while their N-terminal lobe are responsible for the stark functional differences of the calcium sensors. CaBP1 and CaM are thought to modulate CaV function by competing for binding to the CaV C-terminal IQ-domain, but this assumption has never been tested directly. By determining CaV1.2 CDI in Xenopus oocytes under conditions with different ratios of CaM and CaBP1, we demonstrate direct competition between both calcium sensors for their CaV1.2 binding site. In order to extend our analysis of CaBP1/CaM competition we used isothermal titration calorimetry to determine the affinity of both CaM and CaBP1 in both calcium-bound and apo-states for the IQ domain, suggesting that competition occurs mainly in the apo-state. Overall, our data provide a framework for understanding how CaBP1 and CaM differentially regulate CDI on CaV1.2.
gating in human Ca V 1.2 channels, we have optically tracked the activation of the S4 helices of repeats I, III and IV by site-directed fluorescent labeling of introduced Cysteines with thiol-reactive probes. . 0.1 mM ouabain was added to abolish Na þ / K þ ATPase non-linear charge movement. Voltage-dependent fluorescence changes (DF) were reported by fluorophores attached to substituted Cysteines at the extracelular end of the S4 segment in repeats I, III and IV, tracking local, voltage-dependent conformational rearrangements. The voltage dependence of observed fluorescence deflections preceded ionic activation, reporting repeatspecific VSD transitions taking place during shut states of the channel. Prolonged sojourns at depolarized potentials (þ50 mV) shifted the voltagedependence of reported DF to more hyperpolarized potentials by >50mV, recapitulating previously-characterized gating current properties. In summary, we report the first optical characterization of VSD conformational changes in a human voltage-gated Ca 2þ channel, revealing repeat-specific voltage-and time-dependent properties.
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Engineering the Composition of L-Type (Cav1.2) Channels in Heart Cells using Split Intein-Mediated Protein Trans-Splicing Prakash Subramanyam, Donald Chang, Kun Fang, Henry Colecraft. Columbia.University, New York, NY, USA. Ca 2þ influx through L-type (Ca V 1.2) channels in heart regulates excitationcontraction (EC) coupling, action potential duration, and gene expression. This versatility of L-type channels in heart is hypothesized to be mediated in part by differential sub-cellular compartmentalization and hormonal modulation of distinct Ca V 1.2 channel pools in cardiac myocytes. Such prevailing hypotheses are best tested directly in cardiac myocytes, since their unique cyto-architecture and signaling environment cannot be replicated in heterologous cells. There are two major hurdles: first, the large size of pore-forming a 1C subunits exceeds the packaging capacity of viral vectors, necessary to express exogenous Ca V 1.2 channels in adult cardiac myocytes; second, endogenous channels are a source of confounding contaminating signals. To overcome these limitations, we focused on functionally reconstituting two separately expressed moieties of the channel using a novel split-inteinmediated protein splicing approach. In HEK 293 cells, split-intein fragments were trans spliced to generate full-length a 1C as determined by Western blot. When co-expressed with auxiliary b subunits, trans-spliced a 1C trafficked normally to the cell surface and yielded robust whole-cell currents (I Ca ). The split-intein fragments were readily incorporated into adenoviral vectors which when used to infect adult myocytes yielded trans-spliced a 1C that was detected at the cell surface. To isolate exogenous I Ca , we introduced mutations that reduced dihydropyridine sensitivity of trans-spliced a 1C (a 1CDHP-). In the presence of 10 mM nifedipine, myocytes expressing trans-spliced a 1CDHP-yielded significantly larger currents than controls expressing trans-spliced a 1C . The results demonstrate a novel approach to robustly engineer the pore-forming a 1C subunit composition of Ca V 1.2 channels in cardiac myocytes, removing a longstanding technical obstacle to L-type channel structure-function studies in heart. University of British Columbia, Vancouver, BC, Canada. Islet amyloid polypeptide (IAPP, Amylin) is responsible for amyloid formation in type 2 diabetes and in islet cell transplants. The mechanism of IAPP toxicity is poorly understood. Here we identify and characterize the toxic species produced during amyloid formation by human IAPP. using a combination of time-dependent biophysical and biological assays, we show that the transiently populated pre-fibrillar intermediates formed in the early phase of amyloid formation are toxic and they are loosely packed with very modest amounts of secondary structure. The only known natural mutation found in mature human IAPP is a Ser20-to-Gly mis-sense mutation, which appears to be associated with an increased risk of early-onset type 2 diabetes. We demonstrate that the mutant accelerates amyloid formation under physiologically relevant conditions. We rationally design another variant at residue 20, S20K-IAPP, which is much slower to aggregate with an 18-fold longer lag phase and inhibits wild type amyloid formation. The pronounced effects of the Ser20 mutants highlight the sensitivity of amyloid formation to the identity of position 20. By comparing the kinetics and toxicity profiles of the two Ser20 mutants to wild type IAPP, we demonstrate that changes in the length of the lag phase directly correlate with changes in the onset and the duration of toxicity. Our findings provide direct evidence that the toxic species are transient intermediates and have implications for the treatment of type 2 diabetes and other amyloid related diseases. 1-42) ) by solid-state NMR (SSNMR), which offers means to characterize metastable amyloid intermediates. (2) As the ASPD level in a brain correlates with the severity of AD, ASPD is likely an intermediate pathogenically relevant to AD.
1842-Plat
( 1) We demonstrate that detailed structural examination by 13 C SSNMR is possible on synthetic ASPD that well mimics native ASPD isolated from a brain extract from an AD patient. Electron micrograph and immunological analyses using an ASPD-specific ''conformational'' antibody confirm that morphologies and conformations of the synthetic ASPD used for the present NMR analysis are similar to native ASPD.
13
C SSNMR chemical-shift analysis over 20 residues demonstrated that ASPD is made of a homogeneous conformer that is largely composed of b-sheet structure. An inter-strand 13 CO-13 CO distance measurement suggests that the ASPD involves a parallel b-sheet arrangement despite the fact that ASPD does not bind to fibril-specific dyes such as thioflavin-T. The structural features of ASPD will be compared with those of amyloid fibril for Ab(1-42), which were elucidated by SSNMR analysis. The approach presented here is likely to open an avenue to examine structural details of various amyloid intermediate species pathologically relevant to AD or other amyloid diseases, for which structures have been poorly characterized.
